Skip to main content

Table 1 Bibliographical characteristics of 102 included systematic reviews

From: Methodological quality of systematic reviews on treatments for Alzheimer’s disease: a cross-sectional study

Bibliographical characteristics

Resultsa

Cochrane SRs

 - Yes

10 (9.8)

 - No

92 (90.2)

An update of a previous SR

 - Yes

14 (13.7)

 - No

88 (86.3)

Publication year

 2014–2015

36 (35.3)

 2016–2018

29 (28.4)

 2019–2021

37 (36.3)

Publication journal impact factor in the year before SR publication, median [range]

3.26 [0.17,8.77]

Number of review authors, median [range]

5 [2,17]

Location of the corresponding author

 - Europe

18 (17.6)

 - America

12 (11.8)

 - Asia

68 (66.7)

 - Oceania

3 (2.9)

 - Africa

1 (1.0)

Funding location of the SR

 - Europe

15 (14.7)

 - America

7 (6.9)

 - Asia

35 (34.3)

 - Oceania

2 (2.0)

 - No funding

21 (20.6)

 - Not reported

22 (21.6)

Type of treatment

 - Pharmacological treatments

77 (75.5)

 - Non-pharmacological interventions

19 (18.6)

 - Both types

6 (5.9)

Total number of included primary studies

1158

Median number of included primary studies[range]

7 [2,69]

Total number of participants included in primary studies

244,216

Median number of participants included in primary studies[range]

926.5 [57,20132]

SRs reporting intervention harmsb

80 (78.4)

 Pharmacological treatments

65 (84.4)

 Non-pharmacological interventions

11 (57.9)

 Both types

4 (66.7)

SRs that search for English databases

102 (100)

SRs that search for non-English databases

 - Yes

51 (50.0)

 - No

51 (50.0)

Included a PRISMA-like flow diagram

 - Yes

87 (85.3)

 - No

15 (14.7)

Search terms reported for electronic databases

 - No search terms reported

2 (2.0)

 - Topics/free text/keywords/MeSH

61 (59.8)

 - Full Boolean

37 (36.3)

 - Readers are referred elsewhere for full search strategy

2 (2.0)

Report year span of search

 - Yes, reported both starting and ending years

50 (49.0)

 - Partially (only reported starting year or ending year)

49 (48.0)

 - Not mentioned

3 (2.9)

Language restrictions of primary studies

 - English only

24 (23.5)

 - Language other than English

1 (1.0)

 - English and language other than English

53 (52.0)

 - Not reported

24 (23.5)

Methodological quality assessment tools

 - Cochrane risk of bias tool

67 (65.7)

 - Jadad scale

8 (7.8)

 - Pedro Scale

1 (1.0)

 - Delphi list

1 (1.0)

 - More than one tools

6 (5.9)

 - Other tools

7 (6.9)

 - Name of the assessment tool not reported

7 (6.9)

 - No quality assessment conducted

5 (4.9)

  1. SR systematic review, PRISMA Preferred Reporting Items for Systematic Reviews and Meta-analysis, MeSH Medical Subject Headings
  2. aValues are N (%) or median [range]
  3. bPercentages were calculated by using the total number of the categories as the denominator